Hydrogels: A Promising Vehicle for the Topical Management of Atopic Dermatitis
- 5 May 2021
- journal article
- review article
- Published by Wiley in Advanced Therapeutics
- Vol. 4 (7) , 2100028
Abstract
Atopic dermatitis (AD) is an inflammatory skin disease with a high worldwide prevalence. AD is characterized by fluctuating and recurrent eczematous lesions and intense itch, being associated with high physical and psychological impact leading to disturbed sleep quality, anxiety, and depression. Most of the patients have mild to moderate forms of atopic dermatitis and topical therapies (emollients, corticosteroids, calcineurin, and phosphodiesterase 4 inhibitors) are the mainstay of therapy for these patients. Hydrogels are explored in the field of cutaneous application and have proven to be a good solution as a topical vehicle for atopic dermatitis, due to their high water content, improved drug delivery, responsiveness to stimuli and versatility in terms of preparation and drug‐loading, representing a good alternative to regular ointments or creams. This review highlights some of the atopic dermatitis characteristics and the use of hydrogels in the management of this disease. An outline of hydrogels as drug delivery systems for bioactive compounds is discussed, as well as their major advantages and drawbacks when compared to other galenic forms, and also an overview of clinical trials and patents engaged in the past 20 years.Keywords
This publication has 78 references indexed in Scilit:
- Hydrogel-gauze dressing for moderate-to-severe atopic dermatitis: development and efficacy study on atopic dermatitis-like skin lesions in NC/Nga miceDrug Development and Industrial Pharmacy, 2013
- Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment RecommendationsPediatric Drugs, 2013
- Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug useAdvances in Dermatology and Allergology, 2013
- Rational and ethical use of topical corticosteroids based on safety and efficacyIndian Journal of Dermatology, 2012
- Therapeutic effects of Baicalein on atopic dermatitis-like skin lesions of NC/Nga mice induced by dermatophagoides pteronyssinusInternational Immunopharmacology, 2010
- Chapter 4. Antibacterial/steroid combination therapy in infected eczemaActa Dermato-Venereologica, 2008
- Effect of Desonide Hydrogel 0.05% on the Hypothalamic‐Pituitary‐Adrenal Axis in Pediatric Subjects with Moderate to Severe Atopic DermatitisPediatric Dermatology, 2007
- Topical vitamin B12-a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trialBritish Journal of Dermatology, 2004
- Hydrogels in pharmaceutical formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Methods for Synthesis of Hydrogel Networks: A ReviewJournal of Macromolecular Science, Part C: Polymer Reviews, 1996